Bio-Techne (TECH) Intangibles (2009 - 2026)
Bio-Techne (TECH) posted quarterly Intangibles of $895.9 million for Q1 2026, up 101.91% year-over-year from $443.7 million in Q1 2025, and up 167.44% quarter-over-quarter from $335.0 million in Q4 2025.
Bio-Techne (TECH) Intangibles (2009 - 2026) Analysis & Trends
Bio-Techne's Intangibles history runs 18 years deep, the most recent figure standing at $895.9 million for Q1 2026.
- In Q1 2026, Intangibles rose 101.91% year-over-year to $895.9 million; the TTM figure through Mar 2026 stood at $895.9 million (up 101.91% YoY), while the FY2025 annual figure was $365.6 million, up 450.6% from the prior year.
- Intangibles for Q1 2026 stood at $895.9 million, up from $335.0 million in the prior quarter.
- The five-year high for Intangibles was $895.9 million in Q1 2026, with the low at $22.7 million in Q1 2022.
- The 5-year median for Intangibles is $461.1 million (2024), against an average of $399.2 million.
- Peak annual rise in Intangibles reached 2119.07% in 2024, while the deepest fall reached 87.58% in 2024.
- Bio-Techne's Intangibles stood at $75.6 million in 2022, then surged by 598.29% to $527.9 million in 2023, then fell by 12.66% to $461.1 million in 2024, then slipped by 27.34% to $335.0 million in 2025, then soared by 167.44% to $895.9 million in 2026.
- Business Quant data shows TECH's Intangibles at $895.9 million in Q1 2026, $335.0 million in Q4 2025, and $350.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Bio-Techne | 11.33 Bn | 11.12 Bn | 208.29 Mn | 895.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 895.88 Mn |
| Dec 31, 2025 | 334.99 Mn |
| Sep 30, 2025 | 350.11 Mn |
| Jun 30, 2025 | 365.60 Mn |
| Mar 31, 2025 | 443.70 Mn |
| Dec 31, 2024 | 461.05 Mn |
| Sep 30, 2024 | 486.00 Mn |
| Jun 30, 2024 | 66.40 Mn |
| Mar 31, 2024 | 503.73 Mn |
| Dec 31, 2023 | 527.91 Mn |
| Sep 30, 2023 | 578.97 Mn |
| Jun 30, 2023 | 534.65 Mn |
| Mar 31, 2023 | 22.70 Mn |
| Dec 31, 2022 | 75.60 Mn |
| Sep 30, 2022 | 585.53 Mn |
| Jun 30, 2022 | 531.52 Mn |
| Mar 31, 2022 | 22.70 Mn |
| Sep 30, 2021 | 615.97 Mn |
| Jun 30, 2021 | 615.97 Mn |
| Mar 31, 2021 | 8.92 Mn |